Research programme: histone deacetylase inhibitors - CrystalGenomics
Alternative Names: CG0005; CGMC0005; CGMC0006; HDAC inhibitors research programme - CrystalGenomicsLatest Information Update: 16 Jul 2016
At a glance
- Originator CrystalGenomics
- Class Amides; Piperidines; Small molecules
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in European Union (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in South Korea (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in South Korea